STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,371 | +127.7% | 348,069 | +514.7% | 0.12% | +95.0% |
| Q2 2023 | $602 | +79.2% | 56,626 | +40.3% | 0.06% | +81.8% |
| Q1 2023 | $336 | -49.2% | 40,364 | -43.6% | 0.03% | -59.8% |
| Q4 2022 | $661 | -99.9% | 71,572 | -4.7% | 0.08% | -35.9% |
| Q3 2022 | $965,000 | +13.3% | 75,127 | +85.5% | 0.13% | +12.3% |
| Q1 2022 | $852,000 | +45.1% | 40,495 | +65.5% | 0.11% | +54.1% |
| Q4 2021 | $587,000 | +136.7% | 24,467 | +150.9% | 0.07% | +196.0% |
| Q3 2021 | $248,000 | – | 9,753 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |